🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn if histotripsy plus chemotherap...
Status
Recruiting
Location
Cleveland Clinic, Case Comprehensive Cancer Center
Start Date
2025-06-30
Trial ID
NCT07044362
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2019-05-20
Trial ID
NCT03524261
Treatments Being Tested
This is a two-group, parallel, randomized, standard-control phase II study ...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-09-01
Trial ID
NCT05077839
Treatments Being Tested
Study is aimed at evaluating the activity of Trabectedin (arm A) in advance...
Status
Recruiting
Location
Azienda Ospedaliera S. Orsola-Malpighi
Start Date
2021-10-29
Trial ID
NCT04383119
Treatments Being Tested
Lurbinectedin is mainly eliminated by the liver. Thus, Hepatic Impairment (...
Status
Unknown
Location
Hospital Universitario Virgen de la Victoria
Start Date
2021-03-09
Trial ID
NCT05101265
Treatments Being Tested
The most common treatment for Posttraumatic Stress Disorder (PTSD) is traum...
Status
Enrolling By Invitation
Location
The Royal Ottawa Mental Health Centre
Start Date
2024-03-30
Trial ID
NCT05427500
Treatments Being Tested
The study is a multicenter, open-label, randomized controlled clinical stud...
Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-20
Trial ID
NCT04928807
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
A Phase I dose-finding stage for the LB-100 plus doxorubicin combination is...
Status
Active Not Recruiting
Location
Hospital de la Santa Creu i Sant Pau
Start Date
2023-05-29
Trial ID
NCT05809830
Treatments Being Tested